Literature DB >> 17984678

Amiloride 10 mg is less effective than spironolactone 25 mg in patients with hypertension resistant to a multidrug regime including an angiotensin-blocking agent.

Deirdre A Lane, D Gareth Beevers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17984678     DOI: 10.1097/HJH.0b013e3282f254d9

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  7 in total

Review 1.  Personalizing the diuretic treatment of hypertension: the need for more clinical and research attention.

Authors:  Samuel J Mann; Michael E Ernst
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

Review 2.  Drug therapy of apparent treatment-resistant hypertension: focus on mineralocorticoid receptor antagonists.

Authors:  Daniel Glicklich; William H Frishman
Journal:  Drugs       Date:  2015-04       Impact factor: 9.546

3.  Hypertension: spironolactone and resistant hypertension.

Authors:  Jonathan S Williams
Journal:  Nat Rev Endocrinol       Date:  2010-05       Impact factor: 43.330

4.  Resistant hypertension workup and approach to treatment.

Authors:  Anastasios Makris; Maria Seferou; Dimitris P Papadopoulos
Journal:  Int J Hypertens       Date:  2010-12-26       Impact factor: 2.420

5.  Common secondary causes of resistant hypertension and rational for treatment.

Authors:  Charles Faselis; Michael Doumas; Vasilios Papademetriou
Journal:  Int J Hypertens       Date:  2011-03-02       Impact factor: 2.420

6.  Clinical approach in treatment of resistant hypertension.

Authors:  Jennifer Frank; David Sommerfeld
Journal:  Integr Blood Press Control       Date:  2009-07-30

7.  7th Brazilian Guideline of Arterial Hypertension: Chapter 13 - Resistant Arterial Hypertension

Authors:  M V B Malachias; C I S Rodrigues; E Muxfeldt; G F Salles; H Moreno; M Gus
Journal:  Arq Bras Cardiol       Date:  2016-09       Impact factor: 2.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.